Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Eileen Scully, MD, PhD
Johns Hopkins University
Study Chair - Rajesh Gandhi, MD
Massachusetts General Hospital (MGH) CRS
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Puerto Rico Aids Clinical Trials Unit Crs
San Juan, Puerto Rico
- Alabama Crs
Birmingham, Alabama, United States
- Ucla Care Center Crs
Los Angeles, California, United States
- Ucsf Hiv/aids Crs
San Francisco, California, United States
- Harbor-Ucla Crs
Torrance, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Whitman-Walker Health Crs
Washington D.C., District of Columbia, United States
- the Ponce de Leon Center Crs
Atlanta, Georgia, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Massachusetts General Hospital Crs (mgh Crs)
Boston, Massachusetts, United States
- New Jersey Medical School Clinical Research Center Crs
Newark, New Jersey, United States
- Chapel Hill Crs
Chapel Hill, North Carolina, United States
- Greensboro Crs
Greensboro, North Carolina, United States
- Cincinnati Clinical Research Site
Cincinnati, Ohio, United States
- Penn Therapeutics, Crs
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Apr 2018
- Primary completion
- 4 Dec 2018
- Completion
- 27 Jul 2023
- Last update posted
- 3 Jul 2024
- Registered enrollment
- 31
- Registry id
- NCT03382834
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.